Health Canada
Symbol of the Government of Canada
Consumer Product Safety

Incident Report

Subform I: General Information

1. Report Type.

New incident report

Incident Report Number: 2008-1887

2. Registrant Information.

Registrant Reference Number: 282544

Registrant Name (Full Legal Name no abbreviations): Bell Laboratories, Inc.

Address: 3699 Kinsman Blvd

City: Madison

Prov / State: WI

Country: USA

Postal Code: 53704

3. Select the appropriate subform(s) for the incident.

Domestic Animal

4. Date registrant was first informed of the incident.

24-JAN-08

5. Location of incident.

Country: UNITED STATES

Prov / State: TEXAS

6. Date incident was first observed.

24-JAN-08

Product Description

7. a) Provide the active ingredient and, if available, the registration number and product name (include all tank mixes). If the product is not registered provide a submission number.

Active(s)

PMRA Registration No.       PMRA Submission No.       EPA Registration No. 12455-79-3240

Product Name: Tomcat Ultra Block Bait

  • Active Ingredient(s)
    • BROMADIOLONE
      • Guarantee/concentration .005 %

PMRA Registration No.       PMRA Submission No.       EPA Registration No.

Product Name: Bivon (veterinary pharmeceutical used to cause abortion in cattle)

  • Active Ingredient(s)

7. b) Type of formulation.

Bait

Tablet

Application Information

8. Product was applied?

Yes

9. Application Rate.

Unknown

10. Site pesticide was applied to (select all that apply).

Site: Res. - In Home / Rés. - à l'int. maison

11. Provide any additional information regarding application (how it was applied, amount applied, the size of the area treated etc).

Please refer to field 13 on Subform II or field 17 of subform III for a detailed description regarding application.

To be determined by Registrant

12. In your opinion, was the product used according to the label instructions?

Yes

Subform III: Domestic Animal Incident Report

1. Source of Report

Animal's Owner

2. Type of animal affected

Dog / Chien

3. Breed

Mixed Breed

4. Number of animals affected

1

5. Sex

Unknown

6. Age (provide a range if necessary )

0.003

7. Weight (provide a range if necessary )

1.00

lbs

8. Route(s) of exposure

Unknown

9. What was the length of exposure?

Unknown / Inconnu

10. Time between exposure and onset of symptoms

Unknown / Inconnu

11. List all symptoms

System

  • Reproductive System
    • Symptom - Stillborn infant
  • General
    • Symptom - Death

12. How long did the symptoms last?

Persisted until death

13. Was medical treatment provided? Provide details in question 17.

No

14. a) Was the animal hospitalized?

No

14. b) How long was the animal hospitalized?

15. Outcome of the incident

Died

16. How was the animal exposed?

Other / Autre

specify transplacental

17. Provide any additional details about the incident

(eg. description of the frequency and severity of the symptoms

1/24/2008 10:17:21 PM The caller¿s 15lb dog may have ingested 1 block of the product 2 hours prior to the call. The block was within the dog's reach and when caller checked on the dog, the block was missing. The dog is currently whelping. The first puppy was stillborn. The caller also mentioned that his dog may have ingested "Bivon, a cow abortion pill" but does not know when this may have occurred. Upon follow up 1 week later, the owner relayed that the mother and subsequent puppies have all remained healthy. Medical care was not sought nor was a necropsy performed on the deceased puppy.


To be determined by Registrant

18. Severity classification (if there is more than 1 possible classification

Death

19. Provide supplemental information here

The information contained in this report is based on self-reported statements provided to the registrant during telephone Interview(s). These self-reported descriptions of an incident have not been independently verified to be factually correct or complete descriptions of the incident. For that reason, information contained in this report does not and can not form the basis for a determination of whether the reported clinical effects are causally related to exposure to the product identified in the telephone interviews.